Home › NDC Lookup › RxCUI directory › RxCUI 2734124

Thiotepa 400 MG Injection — RxCUI 2734124

Name: Thiotepa 400 MG Injection (RxCUI 2734124)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic clinical drug

RxCUI 2734124 Semantic clinical drug · SCD ● Current RxNorm concept 4 FDA products 4 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2734124

Official nameThiotepa 400 MG Injection

Concept typeSemantic clinical drug (SCD)

RxNorm statusCurrent RxNorm concept

Also known asTSPA 400 MG Injection

FDA products mapped4

Package NDCs mapped4

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Thiotepa Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

It is a chemotherapy medicine. Tepadina is used before stem cell transplant in children with class 3 beta-thalassemia. It is also used for breast or ovarian adenocarcinoma, cancer-...
A healthcare team gives it to you. Depending on the use, it goes into a vein, into a body cavity, or into your bladder through a catheter. Your team decides the schedule and checks...
Low blood counts are very common. You may also get mouth sores, diarrhea, rash, bleeding, blood in the urine, nausea and tiredness. Call right away for fever, signs of infection, u...
Thiotepa can leave your body partly through the skin and cause discoloration, itching, blistering or peeling. The label advises bathing at least twice daily through 48 hours after...

📖 Read our full Thiotepa Injection guide →

🕸️ Concept Web — How Thiotepa 400 MG Injection Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Thiotepa 400 MG Injection RxCUI 2734124 Semantic clinical drug · SCD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 1

The active substance itself — no strength, form, or brand attached yet.
- Thiotepa 10473 IN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Tepadina 1366537 BN
Dose forms 6

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Thiotepa Injection 1660003 SCDF
- Thiotepa Injectable Product 1156487 SCDG
- Thiotepa Injection [Tepadina] 1919207 SBDF
- Tepadina Injectable Product 1919208 SBDG
- Injection 1649574 DF
- Injectable Product 1151126 DFG
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Thiotepa 400 MG 2734123 SCDC
- Thiotepa 400 MG Injection [Tepadina] 2734126 SBD
- Thiotepa 400 MG [Tepadina] 2734125 SBDC

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Thiotepa 400 MG SCDC · 2734123
Thiotepa Injection SCDF · 1660003
Thiotepa Injectable Product SCDG · 1156487

Brand-Name Concepts

Thiotepa 400 MG Injection [Tepadina] SBD · 2734126
Thiotepa 400 MG [Tepadina] SBDC · 2734125
Thiotepa Injection [Tepadina] SBDF · 1919207
Tepadina Injectable Product SBDG · 1919208
Tepadina BN · 1366537

📦 FDA Products & Package NDCs

4 products · 4 package NDCs

4 package NDCs map to RxCUI 2734124 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
70121-1630-01	1 VIAL, GLASS in 1 BOX (70121-1630-1) / 1 INJECTION, POWDER...	TEPADINA	Amneal Pharmaceuticals LLC	2017-08-15
70121-1631-01	1 VIAL, GLASS in 1 BOX (70121-1631-1) / 1 INJECTION, POWDER...	TEPADINA	Amneal Pharmaceuticals LLC	2017-08-15
70121-1687-01	1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 BOX (701...	TEPADINA	Amneal Pharmaceuticals LLC	2025-04-18
70121-2749-01	1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 BOX (701...	TEPADINA	Amneal Pharmaceuticals LLC	2025-04-18

Observed labelers: Amneal Pharmaceuticals LLC (4) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.

Code	Descriptor	Mapped packages	Sources
J9342	Inj thiotepa nos 1 mg	3	CMS

⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.